ANI Bolsters US Generics Offering With Two Launches

Monoket And Carbatrol Rivals Set To Strengthen ANI’s Limited-Competition Portfolio

ANI Pharmaceuticals
(Shutterstock)

More from Generics

More from Generics Bulletin